Short Interest in Healios K.K. (OTCMKTS:HLOSF) Expands By 13.1%

Healios K.K. (OTCMKTS:HLOSF) was the target of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 422,700 shares, an increase of 13.1% from the June 15th total of 373,600 shares. Based on an average daily volume of 200 shares, the short-interest ratio is currently 2,113.5 days.

Healios K.K. Stock Performance

Shares of OTCMKTS HLOSF remained flat at 1.21 on Tuesday. Healios K.K. has a 52-week low of 0.93 and a 52-week high of 1.31. The company has a 50-day simple moving average of 1.08 and a 200 day simple moving average of 1.06.

Healios K.K. Company Profile

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.